SCHEMBL6188068

SCHEMBL6188068

CC(=O)C(SC(c1ccc(Cl)cc1)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.46
CNR1 P21554 3/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
IDO1 P14902 2/20 0.41
TDO2 P48775 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
EPHX1 P07099 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CACNA1A O00555 1/20 0.38
CACNA2D1 P54289 1/20 0.38
CACNB1 Q02641 1/20 0.38
NTRK1 P04629 1/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6186523 0.86 BRD4 (0.45) BRD4SLC6A4SLC6A3
SCHEMBL6077411 0.79 LMNA (0.53) BRD4CNR1MEN1KMT2ACYP2C19
SCHEMBL6186896 0.77 PDPK1 (0.47) BRD4CNR1SLC6A4SLC6A3CYP2D6
SCHEMBL6186361 0.77 PPARG (0.43) BRD4SLC6A4SLC6A3SLC6A2
SCHEMBL28419252 0.75 BRD4 (0.55) BRD4CNR1SLC6A4SLC6A3IDO1
SCHEMBL6187038 0.75 BRD4 (0.50) BRD4CNR1SLC6A4SLC6A3MEN1
SCHEMBL6192279 0.73 BRD4 (0.45) BRD4SLC6A4SLC6A3MEN1KMT2A
SCHEMBL6187841 0.72 CYP2D6 (0.43) SLC6A4SLC6A3IDO1TDO2MEN1
SCHEMBL3691019 0.71 BRD4 (0.59) BRD4CNR1SLC6A4SLC6A3IDO1
SCHEMBL10334603 0.70 PDPK1 (0.60) SLC6A4SLC6A3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539685-A1 MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF Warner-Lambert Company LLC (US) 2005-06-15 EP disclosed
WO-2004014847-A1 MCP-1 RECEPTOR ANTAGONISTS AND METHOD OF USE THEREOF WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed